Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,027 public trials 2,025 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction

NCT03734198

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Chu Amiens Sud Amiens, France
  • CH Annecy Genevois - Hématologie A3 Annecy, France
  • CHU Jean Minjoz - Hématologie Besançon, France
  • Hôpital Avicenne - Centre de Recherche Clinique Bobigny, France
View all 24 locations
View Trial Details
Active, Not Recruiting

Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL

NCT03740334

Conditions
Acute Lymphoblastic Leukemia ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Nemours/Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)

NCT05030155

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • Service de Médecine Interne, Centre de référence " Maladies systémiques et autoimmunes rares, en particulier Vascularites nécrosantes et Sclérodermies systémiques "Hôpital Cochin Paris, France
View Trial Details
Active, Not Recruiting

Personalized Risk Stratification Model of Follicular Lymphoma Patients

NCT03436602

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Arcispedale Santa Maria Nuova, AUSL IRCSS, Hematology Department Reggio Emilia, RE, Italy
  • Azienda Ospedaliera Universitaria Maggiore della Carità Novara, Italy
  • Institute of Oncology Research Bellinzona, Canton Ticino, Switzerland
  • Institute of Pathology Locarno, Canton Ticino, Switzerland
View Trial Details
Active, Not Recruiting

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma

NCT03113500

Conditions
Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, +26 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions